TD Asset Management’s Stoke Therapeutics STOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-26,186
| Closed | -$278K | – | 1448 |
|
|
2023
Q2 | $278K | Hold |
26,186
| – | – | ﹤0.01% | 1347 |
|
|
2023
Q1 | $218K | Hold |
26,186
| – | – | ﹤0.01% | 1373 |
|
|
2022
Q4 | $242K | Hold |
26,186
| – | – | ﹤0.01% | 1376 |
|
|
2022
Q3 | $341K | Sell |
26,186
-8,528
| -25% | -$111K | ﹤0.01% | 1353 |
|
|
2022
Q2 | $459K | Hold |
34,714
| – | – | ﹤0.01% | 1302 |
|
|
2022
Q1 | $731K | Hold |
34,714
| – | – | ﹤0.01% | 1288 |
|
|
2021
Q4 | $833K | Buy |
34,714
+5,600
| +19% | +$134K | ﹤0.01% | 1307 |
|
|
2021
Q3 | $741K | Hold |
29,114
| – | – | ﹤0.01% | 1319 |
|
|
2021
Q2 | $834K | Sell |
29,114
-7,900
| -21% | -$226K | ﹤0.01% | 1295 |
|
|
2021
Q1 | $1.44M | Buy |
37,014
+5,673
| +18% | +$220K | ﹤0.01% | 1182 |
|
|
2020
Q4 | $1.94M | Buy |
31,341
+9,062
| +41% | +$561K | ﹤0.01% | 1046 |
|
|
2020
Q3 | $746K | Hold |
22,279
| – | – | ﹤0.01% | 1144 |
|
|
2020
Q2 | $531K | Hold |
22,279
| – | – | ﹤0.01% | 1197 |
|
|
2020
Q1 | $510K | Buy |
22,279
+2,400
| +12% | +$54.9K | ﹤0.01% | 1167 |
|
|
2019
Q4 | $563K | Hold |
19,879
| – | – | ﹤0.01% | 1225 |
|
|
2019
Q3 | $427K | Buy |
+19,879
| New | +$427K | ﹤0.01% | 1199 |
|